CN103347406B - 使用β-羟基-β-甲基丁酸盐改善脑部发育和认知功能的方法 - Google Patents
使用β-羟基-β-甲基丁酸盐改善脑部发育和认知功能的方法 Download PDFInfo
- Publication number
- CN103347406B CN103347406B CN201280009207.4A CN201280009207A CN103347406B CN 103347406 B CN103347406 B CN 103347406B CN 201280009207 A CN201280009207 A CN 201280009207A CN 103347406 B CN103347406 B CN 103347406B
- Authority
- CN
- China
- Prior art keywords
- hmb
- nutritional
- hydroxy
- methylbutyrate
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161443762P | 2011-02-17 | 2011-02-17 | |
| US61/443762 | 2011-02-17 | ||
| US61/443,762 | 2011-02-17 | ||
| PCT/US2012/024817 WO2012112419A1 (en) | 2011-02-17 | 2012-02-13 | Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103347406A CN103347406A (zh) | 2013-10-09 |
| CN103347406B true CN103347406B (zh) | 2015-08-05 |
Family
ID=45757211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280009207.4A Expired - Fee Related CN103347406B (zh) | 2011-02-17 | 2012-02-13 | 使用β-羟基-β-甲基丁酸盐改善脑部发育和认知功能的方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9326956B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2675298A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6034309B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103347406B (cg-RX-API-DMAC7.html) |
| AR (1) | AR085297A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013020643A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2825734C (cg-RX-API-DMAC7.html) |
| MX (1) | MX348708B (cg-RX-API-DMAC7.html) |
| PH (1) | PH12013501671A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG192813A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI565420B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012112419A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG182812A1 (en) | 2010-01-29 | 2012-09-27 | Abbott Lab | Nutritional emulsions comprising calcium hmb |
| WO2011094548A1 (en) | 2010-01-29 | 2011-08-04 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
| US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
| TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
| US9326956B2 (en) | 2011-02-17 | 2016-05-03 | Abbott Laboratories | Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate |
| ES2421187B1 (es) * | 2012-02-23 | 2014-11-26 | Abbott Laboratories | Metodo para mejorar el desarrollo cerebral y la funcion cognitiva usando beta-hidroxi-beta-metilbutirato |
| EP2745708A1 (en) * | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Antidepressant effect of ß-hydroxy-ß-methylbutyrate |
| US20150351438A1 (en) * | 2013-01-29 | 2015-12-10 | Otc Nutrition Llc | Micronutrient Fortification Delivery |
| WO2014127112A1 (en) * | 2013-02-13 | 2014-08-21 | Baylor College Of Medicine | Memory enhancer and actin dynamics |
| US20160029683A1 (en) * | 2013-03-15 | 2016-02-04 | Abbott Laboratories | Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid |
| WO2015148982A1 (en) | 2014-03-27 | 2015-10-01 | Winterfield Roland W | Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy |
| WO2017048708A1 (en) * | 2015-09-16 | 2017-03-23 | Abbott Laboratories | Reduced fat, shelf stable liquid nutritional composition |
| BR112018009406A8 (pt) * | 2015-11-10 | 2019-02-26 | Metabolic Tech Inc | ?composição de aditivo de ração, produto de ração, método para prevenir, eliminar e/ou reduzir crescimento microbiano, e, revestimento para um produto de ração animal? |
| JP7011300B2 (ja) * | 2017-12-19 | 2022-02-10 | 株式会社島田製薬 | HMBCa含有顆粒の製造方法、及びサプリメント |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006062424A2 (en) * | 2004-11-08 | 2006-06-15 | Sgp & Sons Ab | Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system |
| CN101785566A (zh) * | 2010-01-22 | 2010-07-28 | 北京康比特体育科技股份有限公司 | 一种含有hmb的运动饮料 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291525B1 (en) * | 1999-09-08 | 2001-09-18 | Iowa State University Research Foundation, Inc. | Method for improving a human's perception of his emotional state |
| US7445807B2 (en) | 2002-10-15 | 2008-11-04 | Western Holdings, Llc | Agglomerated granular protein-rich nutritional supplement |
| US20050027005A1 (en) | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
| US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| US20060167075A1 (en) | 2005-01-25 | 2006-07-27 | Pearson James P | Modulators of FAAH |
| US20080317886A1 (en) * | 2005-11-03 | 2008-12-25 | Sparkman Dennis R | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
| ES2548432T3 (es) | 2005-12-19 | 2015-10-16 | Abbott Laboratories | Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2 |
| WO2009116546A1 (ja) | 2008-03-18 | 2009-09-24 | 国立大学法人 岡山大学 | 興奮性化学伝達調節剤およびそのスクリーニング法 |
| DK2381784T3 (en) | 2008-12-09 | 2018-10-22 | Metabolic Tech Inc | Nutritional intervention to improve muscle function and strength |
| JP2009155336A (ja) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | 治療剤 |
| TW201117736A (en) | 2009-11-17 | 2011-06-01 | Hui-Chiang Lu | Compositions for sport supplement |
| CN103338658A (zh) | 2010-12-22 | 2013-10-02 | 雅培制药有限公司 | 含有β-羟基-β甲基丁酸钙和共轭亚油酸的营养型产品 |
| EP2658535A1 (en) | 2010-12-27 | 2013-11-06 | Abbott Laboratories | Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
| US9326956B2 (en) | 2011-02-17 | 2016-05-03 | Abbott Laboratories | Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate |
| SG11201405905WA (en) | 2012-03-19 | 2014-11-27 | Abbott Lab | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance |
| MX2015003498A (es) | 2012-09-17 | 2015-06-04 | Abbott Lab | Composiciones que contienen acido beta-hidroxi-beta-metilbutirico y usos de las mismas. |
-
2012
- 2012-02-13 US US13/984,906 patent/US9326956B2/en not_active Expired - Fee Related
- 2012-02-13 CA CA2825734A patent/CA2825734C/en not_active Expired - Fee Related
- 2012-02-13 MX MX2013009528A patent/MX348708B/es active IP Right Grant
- 2012-02-13 CN CN201280009207.4A patent/CN103347406B/zh not_active Expired - Fee Related
- 2012-02-13 SG SG2013062377A patent/SG192813A1/en unknown
- 2012-02-13 EP EP12705748.7A patent/EP2675298A1/en not_active Withdrawn
- 2012-02-13 JP JP2013554520A patent/JP6034309B2/ja not_active Expired - Fee Related
- 2012-02-13 WO PCT/US2012/024817 patent/WO2012112419A1/en not_active Ceased
- 2012-02-13 PH PH1/2013/501671A patent/PH12013501671A1/en unknown
- 2012-02-13 BR BR112013020643A patent/BR112013020643A2/pt not_active IP Right Cessation
- 2012-02-17 TW TW101105347A patent/TWI565420B/zh not_active IP Right Cessation
- 2012-02-17 AR ARP120100566 patent/AR085297A1/es not_active Application Discontinuation
-
2016
- 2016-10-26 JP JP2016209276A patent/JP6340394B2/ja not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006062424A2 (en) * | 2004-11-08 | 2006-06-15 | Sgp & Sons Ab | Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system |
| CN101785566A (zh) * | 2010-01-22 | 2010-07-28 | 北京康比特体育科技股份有限公司 | 一种含有hmb的运动饮料 |
Non-Patent Citations (1)
| Title |
|---|
| 补充β-羟基-β甲基丁酸盐(HMB)在运动训练中的生理效应;曾志刚等;《中国运动医学杂志》;20070110;第26卷(第01期);第120-123页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PH12013501671A1 (en) | 2021-06-02 |
| TWI565420B (zh) | 2017-01-11 |
| CA2825734A1 (en) | 2012-08-23 |
| AR085297A1 (es) | 2013-09-18 |
| TW201309212A (zh) | 2013-03-01 |
| US20140249223A1 (en) | 2014-09-04 |
| WO2012112419A8 (en) | 2014-03-06 |
| US9326956B2 (en) | 2016-05-03 |
| JP2017061483A (ja) | 2017-03-30 |
| CN103347406A (zh) | 2013-10-09 |
| SG192813A1 (en) | 2013-09-30 |
| BR112013020643A2 (pt) | 2016-08-02 |
| JP6340394B2 (ja) | 2018-06-06 |
| WO2012112419A1 (en) | 2012-08-23 |
| JP6034309B2 (ja) | 2016-11-30 |
| CA2825734C (en) | 2016-05-17 |
| JP2014506890A (ja) | 2014-03-20 |
| MX2013009528A (es) | 2013-10-01 |
| MX348708B (es) | 2017-06-26 |
| EP2675298A1 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6340394B2 (ja) | β−ヒドロキシ−β−メチルブチラートを用いて脳の発達および認知機能を改善する方法 | |
| AU2021202459B2 (en) | Nutritional product | |
| US10864281B2 (en) | Inclusion complexes and methods for making the same | |
| EP2685961B1 (en) | Method for treating neurotrauma | |
| US20050147665A1 (en) | Pharmaceutical and nutritional compositions | |
| US20160250169A1 (en) | Compositions and methods for improving cognitive function | |
| CN105407744A (zh) | 含有β-羟基-β-甲基丁酸的低卡路里婴儿配方 | |
| KR20240057401A (ko) | 파라잔틴-기반 카페인 대용 조성물 및 느린 카페인 대사자에서의 이의 사용 방법 | |
| TW201524372A (zh) | 用於提升認知能力的方法及組合物 | |
| EP4353261A1 (en) | Nutraceutic combination and its use in the treatment of neurological disorders | |
| BR102022006625A2 (pt) | Suplemento alimentar e seu uso | |
| Daly et al. | Protein substitutes in PKU; their historical evolution. Nutrients. 2021; 13: 484 | |
| US20210236521A1 (en) | Method For Improving Brain Function And A Dietary Supplement For Use In The Method | |
| US20150352071A1 (en) | Methods for reducing muscle soreness after exercise using beta-hydroxy-beta-methylbutyrate | |
| CN105357984A (zh) | 低卡路里婴儿配制品含有 | |
| US20150250813A1 (en) | Dietary supplement containing phospholipid-dha, folate, and n-acetyl-l-cysteine | |
| ES2421187A1 (es) | Metodo para mejorar el desarrollo cerebral y la funcion cognitiva usando beta-hidroxi-beta-metilbutirato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: J.M.L.Perosa Inventor after: M.M.Martin Inventor after: A.B.Peres Inventor after: M.R.Gonzales Inventor after: R.R.Cabrera Inventor before: J.M.L.Perosa Inventor before: M.M.Martin Inventor before: A.B.Peres Inventor before: M.R.Gonzales Inventor before: R.R.Kenbuleila |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: J. M. L. PEDROSA M. M. MA DING A. B. PEREZ M. R. GONZALEZ R. R. CANBRERA TO: J. M. L. PEDROSA M. M. MA DING A. B. PEREZ M. R. GONZALEZ R. R. CABRERA |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150805 Termination date: 20190213 |